5-(2-(DIMETHYLAMINO)ETHYL)-2,3-DIHYDRO-3-HYDROXY-2-(4-METHOXYPHENYL)-1,5-BENZOTHIAZEPIN-4(5H)-ONE, (2R,3R)-REL-
UNII Q9MDH7V3SC
Substance Identification & Data
This profile provides standardized clinical and technical data for 5-(2-(dimethylamino)ethyl)-2,3-dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5h)-one, (2r,3r)-rel-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Q9MDH7V3SC.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 42399-39-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C20H24N2O3S NZHUXMZTSSZXSB-RBUKOAKNSA-N;NZHUXMZTSSZXSB-MOPGFXCFSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 5-(2-(dimethylamino)ethyl)-2,3-dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5h)-one, (2r,3r)-rel-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.